PUBLISHED ON: July 7, 2016 | Duration: 19 min, 20 sec
Amish Munshi, director at WINSOL Investment Advisers, says that after recent correction in the leading pharma names, investors should look at large cap pharma companies as compared to the niche mid cap players.
